Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 11
Submit an article Journal homepage
116
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Haploidentical hematopoietic stem cell transplantation with ‘Beijing protocol’ in the treatment of T-lymphoblastic lymphoma

Jia-Pei LuDepartment of Hematology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, ChinaView further author information
,
Fu-Xu WangDepartment of Hematology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3365-4428View further author information
ORCID Icon,
Shu-Peng WenDepartment of Hematology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, ChinaORCID Iconhttps://orcid.org/0000-0001-8377-6282View further author information
ORCID Icon,
Xuan LiuDepartment of Hematology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, ChinaView further author information
,
Ying WangDepartment of Hematology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, ChinaView further author information
,
Zhi-Yun NiuDepartment of Hematology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, ChinaORCID Iconhttps://orcid.org/0000-0002-8529-9341View further author information
ORCID Icon &
Xue-Jun ZhangDepartment of Hematology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4984-862XView further author information
ORCID Icon show all
Pages 2748-2751 | Received 30 Dec 2019, Accepted 16 May 2020, Published online: 16 Jun 2020

References

  • Sweetenham JW. Treatment of lymphoblastic lymphoma in adults. Oncol (Williston Park). 2009;23(12):1015–1020.
  • Leukemia and Lymphoma Group, Hematology Branch, Chinese Society of Clinical Oncology. Chinese Expert Consensus on Hematopoietic Stem Cell Transplantation for Lymphoma (2018 Edition). Chin J Oncol. 2018;40(12):927–934.
  • Yuan Y, Zang L, Yue ZJ, et al. Clinical features and prognosis of 74 cases of lymphoblastic lymphoma. Cancer Res Prev Treat. 2018;45(03):154–159.
  • Thomas DA, O’Brien S, Cortes J, et al. Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood. 2004;104(6):1624–1630.
  • Shi YW, Zhou SY, He XH, et al. Autologous hematopoietic stem cell transplantation in chemotherapy-sensitive lymphoblastic lymphoma: treatment outcome and prognostic factor analysis. Chin J Cancer Res. 2015;27(1):66–73.
  • Bersvendsen H, Kolstad A, Blystad A, et al. Multimodal treatment with all-like chemotherapy, auto-sct and radiotherapy for lymphoblastic lymphoma. Acta Oncol. 2014;53(5):680–687.
  • Levine JE, Harris RE, Loberiza FR, et al.; Lymphoma Study Writing Committee, International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry. A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma. Blood. 2003;101(7):2476–2482.
  • Seong HJ, Joon HM, Seok KJ, et al. Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-cvad induction followed by hematopoietic stem cell transplantation. Ann Hematol. 2015;94(4):1–9.
  • Hu MW, Wang HF, Wang L, et al. Outcome of adult T-lymphoblastic lymphoma depends on ALL-type chemotherapy, prognostic factors, and performance of allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore). 2018;97:e11374.
  • Nishiwaki S, Atsuta Y, Tanaka J. Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available? Bone Marrow Transplant. 2013;48(11):1369–1376.
  • Raiola AM, Dominietto A, di Grazia C, et al. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts. Biol Blood Marrow Transplant. 2014;20(10):1573–1579.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.